EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery

Harshavardhan D Patil, Durgacharan A Bhagwat, Sachin S Mali, Suprit D Saoji, Dipali A Nawadkar, Sonali A Chikhalwale, Vijay R Chidrawar, Pooja V Nagime, Chuda Chitasupho, Sudarshan Singh

Indonesian Journal of Pharmacy · 04.05.2026 · 238-256

DOI: 10.22146/ijp.28745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 04.05.2026. Verfasst von Harshavardhan D Patil und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanosized particles are stabilised by polymers and made mostly of amphiphilic lipids known as cubosomes (CUBs). Encapsulating hydrophilic, hydrophobic, and amphiphilic pharmaceuticals is made effective by their internal bi-continuous cubic phase architecture, which gives a high surface area and partitioned aqueous domains. These self-assembled nanoparticles exhibit thermodynamic stability, biocompatibility, and mucoadhesive properties, making them ideal carriers for diverse multiple administration routes, including oral, transdermal, parenteral, and ocular. Problems with medication solubility, bioavailability, and non-specific toxicity are some of the most important ones that CUBs aim to solve. This review presents a comprehensive overview of CUB structure, types, formulation methods, and characterization techniques. The review emphasizes recent advancements in CUB-based delivery of chemotherapeutic agents, including paclitaxel and doxorubicin, cisplatin, methotrexate, and 5-fluorouracil, highlighting their improved pharmacokinetics and reduced systemic toxicity Despite manufacturing challenges, ongoing research into scalable production and novel excipients continues to support their translational promise. CUBs represent a versatile and potent platform in nanomedicine, offering substantial improvements in drug delivery and cancer treatment. Recent advancements in formulation strategies and surface modification is further strengthened their therapeutic potential. Cubosomes as a promising platform in precision oncology and next generation cancer therapeutics.

Zitieren

APA

Patil, H. D., Bhagwat, D. A., Mali, S. S., Saoji, S. D., Nawadkar, D. A., Chikhalwale, S. A., Chidrawar, V. R., Nagime, P. V., Chitasupho, C., & Singh, S. (2026). Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery. Indonesian Journal of Pharmacy, 238-256. https://doi.org/10.22146/ijp.28745

Vancouver

Patil HD, Bhagwat DA, Mali SS, Saoji SD, Nawadkar DA, Chikhalwale SA, et al. Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery. Indonesian Journal of Pharmacy. 2026:238-256. doi:10.22146/ijp.28745

BibTeX
@article{Patil2026,
  author = {Patil, Harshavardhan D and Bhagwat, Durgacharan A and Mali, Sachin S and Saoji, Suprit D and Nawadkar, Dipali A and Chikhalwale, Sonali A and Chidrawar, Vijay R and Nagime, Pooja V and Chitasupho, Chuda and Singh, Sudarshan},
  title = {Advancements in Cubosomes: A Promising Platform for Targeted Anticancer Drug Delivery},
  journal = {Indonesian Journal of Pharmacy},
  year = {2026},
  pages = {238--256},
  doi = {10.22146/ijp.28745}
}
Kostenlos starten →